Skip to main content
Caplight Logo









Triall

Triall

Private
MaarssenHealthcare & Life Scienceshttps://www.triall.io

Last Round

Grant

Feb 3, 2022

Est. Valuation

$935,312.5

Total Funding Raised

$2.99M

Company Overview

Triall is a healthtech company that provides a digital ecosystem of blockchain-integrated software solutions designed to secure and streamline clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Vertical SaaS, Blockchain Infrastructure, Document Management

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

clinical trial managementeClinicalclinical data managementblockchain for healthcareclinical trial softwareeTMFelectronic trial master fileEDCelectronic data captureclinical audit trailvertical SaaSclinical research technologydata integritypharma techclinical trial automationeClinical suite

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Triall Comparables

Compare Triall with similar companies based on industry and business-model similarity.

Triall comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Rymedi
85%
ClinCapture, Inc.
81%
Viedoc
77%

Triall Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 3, 2022
Initial Coin OfferingSep 28, 2021

Triall Investors

Notable investors and investment history

Triall investors
InvestorRounds
Mempool VenturesInitial Coin Offering
Dizer capitalInitial Coin Offering
Oracles Investment GroupInitial Coin Offering
The Kingdom of The NetherlandsGrant
CSP DAOInitial Coin Offering
BlackDragonInitial Coin Offering

Triall Filings

Explore SEC and related filing metadata, where available.

Triall filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Triall's valuation, stock price, and market status.

Is Triall a public or private company?

Triall is a private company.

What is the current stock price of Triall?

Triall is a private company with no public stock price. No recent secondary market data is available.

How much is Triall worth (valuation)?

Triall's valuation is estimated at $935.3K based on funding round data.

Can I buy Triall stock?

Triall shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Triall's last funding round?

Triall's most recent funding round was Initial Coin Offering on September 28, 2021.

Who are the main investors in Triall?

Key investors in Triall include Mempool Ventures, Dizer capital, Oracles Investment Group, CSP DAO.

Will Triall IPO soon?

No public IPO plans have been announced for Triall.

How can I track Triall secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Triall's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMaarssen
Employee Range6
Year Founded2018
Last FundingFeb 3, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?